Published in AIDS Vaccine Week, October 25th, 2004
"The relocation of our corporate headquarters allows us to consolidate our women's health and drug delivery business under one roof, in close proximity to our Philadelphia manufacturing facility for ESTRASORB," commented Nelson M. Sims, president and chief executive officer of Novavax.
"The move is a major step in our strategy to reduce our total number of facilities. Our facilities plan included closing three facilities, consolidating all drug delivery and women's health businesses to the greater...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Vaccine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.